MIRM
Mirum Pharmaceuticals Inc Earnings
$69.06
Earnings Summary
Revenue | $127.79Mn |
Net Profits | $-5.86Mn |
Net Profit Margins | -4.59% |
Mirum Pharmaceuticals Inc’s revenue jumped 64.09% since last year same period to $127.79Mn in the Q2 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 14.52% jump in its revenue since last 3-months.
Mirum Pharmaceuticals Inc’s net profit jumped 76.21% since last year same period to $-5.86Mn in the Q2 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 60.07% jump in its net profits since last 3-months.
Mirum Pharmaceuticals Inc’s net profit margin jumped 85.5% since last year same period to -4.59% in the Q2 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 65.13% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.27 |
EPS Estimate Current Year | -0.27 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.27 - a 17.55% jump from last quarter’s estimates.
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.27.
Key Ratios
Earning Per Share (EPS) | 0 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Mirum Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-12 | -0.27 | 0 | 100% |
2025-05-07 | -0.48 | -0.3 | 37.5% |
2025-08-06 | -0.33 | -0.12 | 63.64% |
